Cargando…

Neutralizing Antibodies Protect against Oral Transmission of Lymphocryptovirus

Epstein-Barr virus (EBV) is a cancer-associated pathogen for which there is no vaccine. Successful anti-viral vaccines elicit antibodies that neutralize infectivity; however, it is unknown whether neutralizing antibodies prevent EBV acquisition. Here we assessed whether passively delivered AMMO1, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Swati, Homad, Leah J., Akins, Nicholas R., Stoffers, Claire M., Lackhar, Stefan, Malhi, Harman, Wan, Yu-Hsin, Rawlings, David J., McGuire, Andrew T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386402/ https://www.ncbi.nlm.nih.gov/pubmed/32724901 http://dx.doi.org/10.1016/j.xcrm.2020.100033

Ejemplares similares

Epidemiological Surveillance of Lymphocryptovirus Infection in Wild Bonobos
por: Yoshida, Tomoyuki, et al.
Publicado: (2016)

Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual
por: Seydoux, Emilie, et al.
Publicado: (2020)

Mountain gorilla lymphocryptovirus has Epstein-Barr virus-like epidemiology and pathology in infants
por: Smiley Evans, Tierra, et al.
Publicado: (2017)

Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation
por: Seydoux, Emilie, et al.
Publicado: (2020)

The First Endogenous Herpesvirus, Identified in the Tarsier Genome, and Novel Sequences from Primate Rhadinoviruses and Lymphocryptoviruses
por: Aswad, Amr, et al.
Publicado: (2014)

Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects
por: Jennewein, Madeleine F., et al.
Publicado: (2021)

mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
por: Stamatatos, Leonidas, et al.
Publicado: (2021)

Epstein-Barr Virus Glycoprotein Antibody Titers and Risk of Nasopharyngeal Carcinoma
por: Coghill, Anna E, et al.
Publicado: (2022)

A single mRNA immunization boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
por: Stamatatos, Leonidas, et al.
Publicado: (2021)

Induction of Encephalitis in Rhesus Monkeys Infused with Lymphocryptovirus-Infected B-Cells Presenting MOG(34–56) Peptide
por: Haanstra, Krista G., et al.
Publicado: (2013)

Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit
por: Hurlburt, Nicholas K., et al.
Publicado: (2022)

Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies
por: Seydoux, Emilie, et al.
Publicado: (2021)

Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
por: Hurlburt, Nicholas K., et al.
Publicado: (2020)

Soluble Rhesus Lymphocryptovirus gp350 Protects against Infection and Reduces Viral Loads in Animals that Become Infected with Virus after Challenge
por: Sashihara, Junji, et al.
Publicado: (2011)

Structural basis for broad coronavirus neutralization
por: Sauer, Maximilian M., et al.
Publicado: (2021)

Immunization with a self-assembling nanoparticle vaccine displaying EBV gH/gL protects humanized mice against lethal viral challenge
por: Malhi, Harman, et al.
Publicado: (2022)

Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
por: Hurlburt, Nicholas K., et al.
Publicado: (2020)

Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodies
por: Whaley, Rachael E., et al.
Publicado: (2021)

New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission
por: McGuire, Kathleen A., et al.
Publicado: (2017)

Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization
por: Ding, Shilei, et al.
Publicado: (2020)

Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients
por: Muecksch, Frauke, et al.
Publicado: (2020)

HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
por: Dufloo, Jérémy, et al.
Publicado: (2018)

COVID-19 and human milk: SARS-CoV-2, antibodies, and neutralizing capacity
por: Pace, Ryan M., et al.
Publicado: (2020)

Neutralizing Antibodies and Antibody-Dependent Enhancement in COVID-19: A Perspective
por: Ajmeriya, Swati, et al.
Publicado: (2022)

HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2018)

Designed proteins assemble antibodies into modular nanocages
por: Divine, Robby, et al.
Publicado: (2020)

Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma
por: Kumar, Amit, et al.
Publicado: (2018)

Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission
por: Malbec, Marine, et al.
Publicado: (2013)

HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission
por: Baan, Elly, et al.
Publicado: (2013)

Lack of protection in vivo with neutralizing monoclonal antibodies to transmissible gastroenteritis virus
por: Wesley, R.D., et al.
Publicado: (1988)

Porcine deltacoronavirus resists antibody neutralization through cell-to-cell transmission
por: Xia, Sijin, et al.
Publicado: (2023)

Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2019)

Characterization of SARS-CoV-2 RNA, Antibodies, and Neutralizing Capacity in Milk Produced by Women with COVID-19
por: Pace, Ryan M., et al.
Publicado: (2021)

Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization
por: Parks, K. Rachael, et al.
Publicado: (2019)

Autophagy-associated dengue vesicles promote viral transmission avoiding antibody neutralization
por: Wu, Yan-Wei, et al.
Publicado: (2016)

Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission
por: Kim, Young-Il, et al.
Publicado: (2021)

HCMV trimer- and pentamer-specific antibodies synergize for virus neutralization but do not correlate with congenital transmission
por: Vanarsdall, Adam L., et al.
Publicado: (2019)

Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters
por: Brandenberg, Oliver F., et al.
Publicado: (2017)

Mechanisms of transmissible gastroenteritis coronavirus neutralization
por: Suñé, Carlos, et al.
Publicado: (1990)

Molecular Signatures of Hemagglutinin Stem-Directed Heterosubtypic Human Neutralizing Antibodies against Influenza A Viruses
por: Avnir, Yuval, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_to74hc378cokgk5o3j01jflf41